| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3376529 | Journal of Infection | 2007 | 8 Pages |
Abstract
In patients receiving HAART who have undetectable viral load, an interruption, no longer than 4 weeks, due to any intercurrent problem seems to be safe. Response to resumption can usually be achieved. Due to the frequent development of resistance, a genotypic test during interruption might be helpful.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Rosario Sanchez, JoaquÃn Portilla, Adelina Gimeno, Vicente Boix, Coral Llopis, Jose Sanchez-Paya, Esperanza Merino, Maria Luz de la Sen, Carlos Muñoz, Sergio Reus, JoaquÃn Plazas,